(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

GEMINI PHARMACEUTICALS

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: CombinedOffice: United States

Quick snapshot

GEMINI PHARMACEUTICALS

ST13

US500000086589877

Class

40

Filing

86589877

Registration

5367162

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

53

Latest update

09/12/2023

Trademark type

Combined

Nice classes

40

Filing date

04/07/2015

Registration date

01/02/2018

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

08/04/2023

Last transaction

08/04/2023

Responsible office

United States Patent and Trademark Office

Status code

702

Official register

Principal Register

First use anywhere

03/25/1982

First use in commerce

03/25/1982

Drawing code

3

Owner type

03

Owner location

Commack, NY

Examiner

GILLES, DEBORAH

Law office

M10

Current location

TMO LAW OFFICE 110

Mark description

The mark consists of a pestle and a mortar with a bottle containing liquid all in blue with the terms "GEMINI" and "PHARMACEUTICALS" in a stylized font in blue.

Holders and representatives

Holders

Gemini Pharmaceuticals, Inc.

Representatives

Neil B. Friedman HODGSON RUSS, LLP

Technical classification

Nice Classes

Class 40

Vienna Codes

No Vienna codes available.

Goods and services

Class 40

Manufacturing services for others in the field of pharmaceutical preparationsvitaminsdietary and nutritional supplementsdietary supplements for petsvitamins for petsmedicinal herb extracts

Publications

History of USPTO decisions and trademark events.

53 publications found

NURC

NOTICE OF UPDATED REGISTRATION CONFIRMATION EMAILED

09/12/2023

NA85

NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED

08/04/2023

C15A

REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.

08/04/2023

A7OK

AMENDMENT UNDER SECTION 7 - PROCESSED

08/04/2023

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

07/28/2023

E815

TEAS SECTION 8 & 15 RECEIVED

02/01/2023

ES7R

TEAS SECTION 7 REQUEST RECEIVED

02/01/2023

REM1

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

01/02/2023

R.PR

REGISTERED-PRINCIPAL REGISTER

01/02/2018

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

10/17/2017

PUBO

PUBLISHED FOR OPPOSITION

10/17/2017

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

09/27/2017

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

09/12/2017

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

08/22/2017

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

08/22/2017

ALIE

ASSIGNED TO LIE

08/15/2017

ERSI

TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED

07/21/2017

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

07/14/2017

GNS3

NOTIFICATION OF LETTER OF SUSPENSION E-MAILED

04/19/2017

GNSL

LETTER OF SUSPENSION E-MAILED

04/19/2017

CNSL

SUSPENSION LETTER WRITTEN

04/19/2017

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

03/30/2017

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

03/30/2017

ERSI

TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED

03/24/2017

GNS2

NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED

03/24/2017

GNSI

INQUIRY TO SUSPENSION E-MAILED

03/24/2017

CNSI

SUSPENSION INQUIRY WRITTEN

03/24/2017

RCCK

SUSPENSION CHECKED - TO ATTORNEY FOR ACTION

03/23/2017

GNS3

NOTIFICATION OF LETTER OF SUSPENSION E-MAILED

09/21/2016

GNSL

LETTER OF SUSPENSION E-MAILED

09/21/2016

CNSL

SUSPENSION LETTER WRITTEN

09/21/2016

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

08/31/2016

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

08/31/2016

ALIE

ASSIGNED TO LIE

08/23/2016

ERSI

TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED

08/15/2016

GNS2

NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED

08/13/2016

GNSI

INQUIRY TO SUSPENSION E-MAILED

08/13/2016

CNSI

SUSPENSION INQUIRY WRITTEN

08/13/2016

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

02/11/2016

GNS3

NOTIFICATION OF LETTER OF SUSPENSION E-MAILED

02/11/2016

GNSL

LETTER OF SUSPENSION E-MAILED

02/11/2016

CNSL

SUSPENSION LETTER WRITTEN

02/11/2016

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

01/20/2016

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

01/19/2016

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

01/19/2016

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

10/14/2015

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

07/20/2015

GNRT

NON-FINAL ACTION E-MAILED

07/20/2015

CNRT

NON-FINAL ACTION WRITTEN

07/20/2015

DOCK

ASSIGNED TO EXAMINER

07/14/2015

MDSC

NOTICE OF DESIGN SEARCH CODE E-MAILED

04/16/2015

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

04/15/2015

NWAP

NEW APPLICATION ENTERED

04/10/2015

Continuous trademark protection

Get notified about every new filing that threatens GEMINI PHARMACEUTICALS or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.